Jiangsu Hengrui Pharmaceuticals (600276.SH): Perfluorohexyl octane eye drops approved for market launch
Hengrui Medicine Co., Ltd. (600276.SH) issued an announcement that recently, its subsidiary Chengdu Shengdi Medicine Co., Ltd. received...
Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that its subsidiary Chengdu Shengdi Pharmaceutical Co., Ltd. has received notification from the China Food and Drug Administration (CFDA) approving the marketing of the company's product perfluorohexane ophthalmic solution for the treatment of dry eyes related to meibomian gland dysfunction (MGD).
Related Articles
US Stock Market Move | TripAdvisor, Inc. (TRIP.US) rises more than 18%, with aggressive investor Starboard Value acquiring over 9% stake.
US Stock Market Move | Drone concept stock Unmanned Machines (UMAC.US) rose more than 6%.
US Stock Market Move | Bitcoin concept stocks continue to rise this week, with Strategy (MSTR.US) rising more than 1.6%.
US Stock Market Move | TripAdvisor, Inc. (TRIP.US) rises more than 18%, with aggressive investor Starboard Value acquiring over 9% stake.
US Stock Market Move | Drone concept stock Unmanned Machines (UMAC.US) rose more than 6%.
US Stock Market Move | Bitcoin concept stocks continue to rise this week, with Strategy (MSTR.US) rising more than 1.6%.
